Show simple item record

dc.contributor.authorAnnibaldi, A
dc.contributor.authorMeier, P
dc.date.accessioned2018-06-22T09:36:28Z
dc.date.issued2018-08-01
dc.identifier.citationCell death and differentiation, 2018, 25 (8), pp. 1361 - 1363
dc.identifier.issn1350-9047
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1898
dc.identifier.eissn1476-5403
dc.identifier.doi10.1038/s41418-018-0135-2
dc.formatPrint
dc.format.extent1361 - 1363
dc.languageeng
dc.language.isoeng
dc.publisherSPRINGERNATURE
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectReceptors, Tumor Necrosis Factor, Type I
dc.subjectUbiquitin
dc.subjectHematopoiesis
dc.subjectReceptor-Interacting Protein Serine-Threonine Kinases
dc.titleRipk1 and haematopoiesis: a case for LUBAC and Ripk3.
dc.typeJournal Article
rioxxterms.versionofrecord10.1038/s41418-018-0135-2
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2018-08
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfCell death and differentiation
pubs.issue8
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Cell Death and Immunity
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Cell Death and Immunity
pubs.publication-statusPublished
pubs.volume25
pubs.embargo.termsNot known
icr.researchteamCell Death and Immunity
dc.contributor.icrauthorMeier, Pascal


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0